Pacira BioSciences, Inc. updated sales guidance for the full year 2023. For the year, the company now expected EXPAREL net product sales of $535 million to $540 million versus the company?s previously guided range of $550 million to $560 million. the company is reiterating the guidance of ZILRETTA net product sales of $110 million to $115 million; iovera° net product sales of $17 million to $20 million.